Heterocyclic inhibitors of MEK and methods of use thereof

Details for Australian Patent Application No. 2006299902 (hide)

Owner AstraZeneca AB Array BioPharma Inc.

Inventors Blake, Jim; Fielding, Mark Richard; Seo, Jeongbeob; Storey, Richard Anthony; Leonard, John; Lyssikatos, Joseph P.; Booth, Rebecca Jane; Yang, Hong Woon; Marlow, Allison L.; Wallace, Eli; Pittam, John David

Agent Watermark

Pub. Number AU-B-2006299902

PCT Pub. Number WO2007/044084

Priority 60/682,335 18.05.05 US

Filing date 17 May 2006

Wipo publication date 19 April 2007

Acceptance publication date 1 November 2012

International Classifications

C07D 211/74 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4412 - having oxo groups directly attached to the heterocyclic ring

A61K 31/50 - Pyridazines

C07D 211/86 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/63 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/70 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 237/12 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 237/14 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2007/044084 Priority application(s): WO2007/044084

1 November 2012 Application Accepted

  Published as AU-B-2006299902

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299918-Methods for preparing glutamic acid derivatives

2006299901-Evolved interferon-alpha polypeptides